Skip to nav Skip to content

Clinical trials play an important role in lung cancer treatment. After a promising new drug or therapy is identified and extensively tested to ensure its safety, clinical trials are conducted to determine its effectiveness in relation to the other treatments that are currently available. All emerging treatments go through this process; even the treatments that are now considered the “gold standard” in cancer care were once only available through clinical trials.

At Moffitt Cancer Center, we have a robust program that focuses exclusively on lung cancer clinical trials. Our trials explore treatments such as:

  • Chemotherapy drugs and combinations
  • Immunotherapy
  • Gene therapy
  • Targeted therapy

Clinical trials are a large part of what we do at Moffitt Cancer Center.

Through our efforts, we’ve compiled one of the largest existing outcomes databases in the nation, which contains more than 13 years of trial results.

Moffitt’s lung cancer research program has been awarded multiple grants by the National Cancer Institute. We have also been named a Comprehensive Cancer Center due to our ability to apply the findings of our research to our patients’ individualized treatment plans. At Moffitt, our trials don’t just benefit the patients who participate; they benefit every future patient whose lives are impacted by lung cancer.

Medically reviewed by Dr. Andreas Saltos.

To learn more about the available lung cancer clinical trials at Moffitt Cancer Center, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form. We don’t require a referral for consultation, and we’ll help you determine if you qualify for one of our trials.